Alcresta Therapeutics
Alexey Margolin, Ph.D. is an experienced biotech entrepreneur, inventor, and CEO. He co-founded and served as CEO of several biotech companies with focus on rare and metabolic diseases, such as Alcresta Therapeutics, Allena Pharmaceuticals, and Alnara Pharmaceuticals (acquired by Eli Lilly in 2010). He is currently Chairman of the Board of Synspira Therapeutics. Earlier in his career Dr. Margolin served as chief scientific officer of Altus Pharmaceuticals where he initiated and led several therapeutic programs based on orally-administered proteins. He is the author of more than 60 publications and is an inventor on numerous patents including invention of the lead Alcresta product RELiZORB for enteral feeding.
Dr. Margolin holds both his M.S. in chemistry and Ph.D. in bio-organic chemistry from Moscow University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices